BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 28752218)

  • 1. Predicting IDH mutation status of intrahepatic cholangiocarcinomas based on contrast-enhanced CT features.
    Zhu Y; Chen J; Kong W; Mao L; Kong W; Zhou Q; Zhou Z; Zhu B; Wang Z; He J; Qiu Y
    Eur Radiol; 2018 Jan; 28(1):159-169. PubMed ID: 28752218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Value of contrast-enhanced CT texture analysis in predicting IDH mutation status of intrahepatic cholangiocarcinoma.
    Zhu Y; Mao Y; Chen J; Qiu Y; Guan Y; Wang Z; He J
    Sci Rep; 2021 Mar; 11(1):6933. PubMed ID: 33767315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mass-forming intrahepatic cholangiocarcinoma: Enhancement patterns in the arterial phase of dynamic hepatic CT - Correlation with clinicopathological findings.
    Fujita N; Asayama Y; Nishie A; Ishigami K; Ushijima Y; Takayama Y; Okamoto D; Moirta K; Shirabe K; Aishima S; Wang H; Oda Y; Honda H
    Eur Radiol; 2017 Feb; 27(2):498-506. PubMed ID: 27165138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognosis and Clinicopathologic Features of Patients With Advanced Stage Isocitrate Dehydrogenase (IDH) Mutant and IDH Wild-Type Intrahepatic Cholangiocarcinoma.
    Goyal L; Govindan A; Sheth RA; Nardi V; Blaszkowsky LS; Faris JE; Clark JW; Ryan DP; Kwak EL; Allen JN; Murphy JE; Saha SK; Hong TS; Wo JY; Ferrone CR; Tanabe KK; Chong DQ; Deshpande V; Borger DR; Iafrate AJ; Bardeesy N; Zheng H; Zhu AX
    Oncologist; 2015 Sep; 20(9):1019-27. PubMed ID: 26245674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiation of mass-forming intrahepatic cholangiocarcinoma from poorly differentiated hepatocellular carcinoma: based on the multivariate analysis of contrast-enhanced computed tomography findings.
    Zhao YJ; Chen WX; Wu DS; Zhang WY; Zheng LR
    Abdom Radiol (NY); 2016 May; 41(5):978-89. PubMed ID: 27193795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors Affecting the Enhancement Patterns of Intrahepatic Cholangiocarcinoma (ICC) on Contrast-Enhanced Ultrasound (CEUS) and their Pathological Correlations in Patients with a Single Lesion.
    Yuan MX; Li R; Zhang XH; Tang CL; Guo YL; Guo DY; Luo MK
    Ultraschall Med; 2016 Dec; 37(6):609-618. PubMed ID: 25919414
    [No Abstract]   [Full Text] [Related]  

  • 7. Preoperative Computed Tomography Features of Intrahepatic Cholangiocarcinoma for Predicting Lymph Node Metastasis and Overall Survival.
    Zhu Y; Mao Y; Chen J; Qiu Y; Wang Z; He J
    J Comput Assist Tomogr; 2019; 43(5):729-735. PubMed ID: 31490892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intratumoral artery on contrast-enhanced computed tomography imaging: differentiating intrahepatic cholangiocarcinoma from poorly differentiated hepatocellular carcinoma.
    Tsunematsu S; Chuma M; Kamiyama T; Miyamoto N; Yabusaki S; Hatanaka K; Mitsuhashi T; Kamachi H; Yokoo H; Kakisaka T; Tsuruga Y; Orimo T; Wakayama K; Ito J; Sato F; Terashita K; Nakai M; Tsukuda Y; Sho T; Suda G; Morikawa K; Natsuizaka M; Nakanishi M; Ogawa K; Taketomi A; Matsuno Y; Sakamoto N
    Abdom Imaging; 2015 Aug; 40(6):1492-9. PubMed ID: 25579172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrahepatic mass-forming cholangiocarcinomas: enhancement patterns at multiphasic CT, with special emphasis on arterial enhancement pattern--correlation with clinicopathologic findings.
    Kim SA; Lee JM; Lee KB; Kim SH; Yoon SH; Han JK; Choi BI
    Radiology; 2011 Jul; 260(1):148-57. PubMed ID: 21474703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequent mutation of isocitrate dehydrogenase (IDH)1 and IDH2 in cholangiocarcinoma identified through broad-based tumor genotyping.
    Borger DR; Tanabe KK; Fan KC; Lopez HU; Fantin VR; Straley KS; Schenkein DP; Hezel AF; Ancukiewicz M; Liebman HM; Kwak EL; Clark JW; Ryan DP; Deshpande V; Dias-Santagata D; Ellisen LW; Zhu AX; Iafrate AJ
    Oncologist; 2012; 17(1):72-9. PubMed ID: 22180306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contrast enhanced CT-scan to diagnose intrahepatic cholangiocarcinoma in patients with cirrhosis.
    Iavarone M; Piscaglia F; Vavassori S; Galassi M; Sangiovanni A; Venerandi L; Forzenigo LV; Golfieri R; Bolondi L; Colombo M
    J Hepatol; 2013 Jun; 58(6):1188-93. PubMed ID: 23485522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement patterns of intrahepatic cholangiocarcinoma: comparison between contrast-enhanced ultrasound and contrast-enhanced CT.
    Chen LD; Xu HX; Xie XY; Lu MD; Xu ZF; Liu GJ; Liang JY; Lin MX
    Br J Radiol; 2008 Nov; 81(971):881-9. PubMed ID: 18941048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamic enhancement pattern of intrahepatic cholangiocarcinoma on contrast-enhanced ultrasound: the correlation with cirrhosis and tumor size.
    Lu Q; Xue LY; Wang WP; Huang BJ; Li CX
    Abdom Imaging; 2015 Aug; 40(6):1558-66. PubMed ID: 25725793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IDH mutations in liver cell plasticity and biliary cancer.
    Saha SK; Parachoniak CA; Bardeesy N
    Cell Cycle; 2014; 13(20):3176-82. PubMed ID: 25485496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrahepatic peripheral cholangiocarcinoma: CT evaluation.
    Valls C; Gumà A; Puig I; Sanchez A; Andía E; Serrano T; Figueras J
    Abdom Imaging; 2000; 25(5):490-6. PubMed ID: 10931983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small intrahepatic peripheral cholangiocarcinomas as mimics of hepatocellular carcinoma in multiphasic CT.
    Mendiratta-Lala M; Park H; Kolicaj N; Mendiratta V; Bassi D
    Abdom Radiol (NY); 2017 Jan; 42(1):171-178. PubMed ID: 27590067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral mass-forming cholangiocarcinoma in cirrhotic liver.
    Kim SJ; Lee JM; Han JK; Kim KH; Lee JY; Choi BI
    AJR Am J Roentgenol; 2007 Dec; 189(6):1428-34. PubMed ID: 18029881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiomics of cholangiocarcinoma on pretreatment CT can identify patients who would best respond to radioembolisation.
    Mosconi C; Cucchetti A; Bruno A; Cappelli A; Bargellini I; De Benedittis C; Lorenzoni G; Gramenzi A; Tarantino FP; Parini L; Pettinato V; Modestino F; Peta G; Cioni R; Golfieri R
    Eur Radiol; 2020 Aug; 30(8):4534-4544. PubMed ID: 32227266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isocitrate Dehydrogenase-Mutated Cholangiocarcinoma: Natural History and Clinical Outcomes.
    Wintheiser G; Zemla T; Shi Q; Tran N; Prasai K; Tella SH; Mody K; Ahn D; Borad M; Bekaii-Saab T; Mahipal A
    JCO Precis Oncol; 2022 Jan; 6():e2100156. PubMed ID: 35005992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrahepatic cholangiocarcinoma: findings on spiral CT during arterial portography.
    Soyer P; Bluemke DA; Hruban RH; Sitzmann JV; Fishman EK
    Eur J Radiol; 1994 Nov; 19(1):37-42. PubMed ID: 7859759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.